  See all
 |
Articles: GI Oncology |
Prior Articles
Upregulated p27kip1 can Downregulate Survivin Expression and Inhibit Telomerase Activity in Gastric Carcinoma Cells
Cancer Investigation, 10/26/09
Silencing of galectin-3 changes the gene expression and augments the sensitivity of gastric cancer cells to chemotherapeutic agents
Cancer Science, 10/26/09 Grading of gastric foveolar-type dysplasia in Barrett's esophagus
Modern Pathology, 10/23/09 Expression of Nucleostemin, epidermal growth factor and epidermal growth factor receptor in human esophageal squamous cell carcinoma tissues
Journal of Cancer Research & Clinical Oncology, 10/23/09 Cisplatin versus cisplatin plus doxorubicin for standard-risk hepatoblastoma
New England Journal of Medicine, 10/22/09 Efficacy of radionuclide treatment DOTATATE Y-90 in patients with progressive metastatic gastroenteropancreatic neuroendocrine carcinomas (GEP-NETs): a phase II study
Annals of Oncology, 10/20/09 Collision tumor of the stomach: Gastric adenocarcinoma intermixed with gastrointestinal stromal tumor
Pathology International, 10/20/09 Candidate Gene Association Study of Esophageal Squamous Cell Carcinoma in a High-Risk Region in Iran
Cancer Research, 10/20/09 Impact of p53 expression and microsatellite instability on stage III colon cancer disease-free survival in patients treated by 5-fluorouracil and leucovorin with or without oxaliplatin
Annals of Oncology, 10/19/09
Exclusive Author Commentary Phase II study of S-1 plus leucovorin in patients with metastatic colorectal cancer
Annals of Oncology, 10/19/09 Involvement of human papillomavirus in upper aero-digestive tracts cancers
Bulletin du Cancer, 10/19/09 A phase II study of intra-arterial chemotherapy of 5-fluorouracil, cisplatin, and mitomycin C for advanced nonresectable gastric cancer
Anti-Cancer Drugs, 10/15/09 Tumour regression grade (TRG) analyses in patients with resectable gastro-oesophageal adenocarcinomas treated with platinum-based neoadjuvant chemotherapy
Histopathology, 10/15/09 Promoter hypermethylation mediates downregulation of thiamine receptor slc19a3 in gastric cancer
Tumor Biology, 10/12/09 Fluorouracil versus combination of irinotecan plus cisplatin versus S-1 in metastatic gastric cancer: a randomised phase 3 study : The Lancet Oncology
The Lancet Oncology - Online First, 10/09/09 Gastric cancer mortality trends in Spain, 1976-2005: differences by autonomous region and sex
BMC Cancer, 10/09/09
Free full text
Alpha-fetoprotein response after locoregional therapy for hepatocellular carcinoma: oncologic marker of radiologic response, progression, and survival
Journal of Clinical Oncology, 10/08/09 Phase I/II study of sunitinib malate in Japanese patients with gastrointestinal stromal tumor after failure of prior treatment with imatinib mesylate
Investigational New Drugs, 10/08/09
Free full text
Secreted LOXL2 is a novel therapeutic target that promotes gastric cancer metastasis via the Src/FAK pathway
Carcinogenesis, 10/08/09 Suppression of gastric cancer dissemination by ephrin-B1-derived peptide
Cancer Science, 10/08/09
|
|
Receive free subspecialty "5-minute updates" via email
|
|
Indexed Journals: Journal of Clinical Oncology, Cancer Research, Annals Oncology
more...
|
250 Available Pages
|
|
